Andrew Oxtoby

2019

In 2019, Andrew Oxtoby earned a total compensation of $3M as Chief Commercial Officer at Aimmune Therapeutics.

Compensation breakdown

Bonus$3,298
Non-Equity Incentive Plan$169,456
Option Awards$1,972,710
Salary$396,667
Stock Awards$263,280
Other$145,968
Total$2,951,379

Oxtoby received $2M in option awards, accounting for 67% of the total pay in 2019.

Oxtoby also received $3.3K in bonus, $169.5K in non-equity incentive plan, $396.7K in salary, $263.3K in stock awards and $146K in other compensation.

Rankings

In 2019, Andrew Oxtoby's compensation ranked 4,158th out of 13,971 executives tracked by ExecPay. In other words, Oxtoby earned more than 70.2% of executives.

ClassificationRankingPercentile
All
4,158
out of 13,971
70th
Division
Manufacturing
1,514
out of 5,695
73rd
Major group
Chemicals And Allied Products
530
out of 2,194
76th
Industry group
Drugs
446
out of 1,880
76th
Industry
Pharmaceutical Preparations
342
out of 1,392
75th
Source: SEC filing on April 9, 2020.

Oxtoby's colleagues

We found four more compensation records of executives who worked with Andrew Oxtoby at Aimmune Therapeutics in 2019.

2019

Jayson Dallas

Aimmune Therapeutics

Chief Executive Officer

2019

Eric Bjerkholt

Aimmune Therapeutics

Chief Financial Officer

2019

Douglas Sheehy

Aimmune Therapeutics

General Counsel

2019

Daniel Adelman

Aimmune Therapeutics

Chief Medical Officer

News

In-depth

You may also like